HomeOpen Access NewsOptical Health

Optical Health

Switching to faricimab for patients with diabetic macular oedema

A recent study, published in the journal Nature looked into the six-month impact of switching neovascular age-related macular degeneration and diabetic macular oedema patients to faricimab instead of anti-VEGF therapy.

Clinical Endpoints and data management in the era of ophthalmic precision medicine

Eric Buckland of Translational Imaging Innovations and Ronald Schuchard, Clinical Product Development Expert, explore the benefits of ophthalmic precision medicine to improve patient care across sectors.

Could reducing screen time slow down the aging process?

Excessive screen time is linked to obesity, psychological problems and even acceleration of aging - could reducing blue light really slow down the aging process?

The role optical practices play in dealing with eye problems

Daryl Newsome FBDO R CL SMC(Tech), President of the Association of British Dispensing Opticians, examines the important role that optical practices can play in dealing with eye problems.

Blue light exposure: What are the dangers?

Daily, lifelong exposure to blue light which comes from phones, computers and household fixtures can worsen with age.

Data capture for researching degenerative eye disease

Translational Imaging Innovations makes data accessible to research degenerative eye disease.

All people with blue eyes have one common ancestor 

Scientists reveal that a genetic mutation, happening around 10,000 years ago, led to the repression of melanin for humans with blue eyes.

Accelerating design & manufacture in the eye care sector

Nick Walsh, updates us on the fast-moving developments in the eye care sector, specifically on the design & manufacture of frames for glasses.

The global cost of visual impairment

250 million people suffer from visual impairment at a global cost of $3 trillion, Translational Imaging Innovations explain.

The time is right to prioritise eye health research

Keith Valentine, Chief Executive of Fight for Sight, explains why eye health research needs to be on the political agenda.

New stem cell model of albinism to study related eye conditions

First patient-derived stem cell model for studying eye conditions related to oculocutaneous albinism developed by the National Eye Institute Lead author of the report, Doctor...

Academic and translational research for ophthalmic conditions

Professor Sheardown shows C20/20 Innovation Hub at McMaster University leading the way for ophthalmic academic and translational research

Sjögren’s syndrome: A call for more visibility and solutions

European federation Sjögren Europe’s board members emphasise the need for research into this underrepresented and “invisible” condition

Sounds of the Universe: Inclusive experience for visually impaired astronomers

New project to allow blind or partially sighted individuals to ‘hear’ the universe is providing a more inclusive side to astronomy This research is offering...

NIH discover new potential therapy for eye diseases

A new study shows promise for future therapies for blinding eye diseases, uveitis and multiple sclerosis.

The impact of the pandemic on children’s eyesight

Max Halford, Clinical Lead at the Association of British Dispensing Opticians, discusses the impact of the pandemic on children’s eyesight across the UK.

Myopia management: Looking after the “other” pandemic

Max Halford FBCO CL, Clinical Lead at Association of British Dispensing Opticians, turns our thoughts towards the “other” pandemic, myopia management.

Advertisements


Latest Academic Articles

The latest academic articles from key research stakeholders